Session – How to generate value for clinical stage companies with CMC strategy for commercial readiness Daniel Hogan is a formulation and tech transfer scientist with over 20 years experience working for a wide range of companies and a broad collection of products and dosage forms. He has brought products over the counter and prescription products to the market using his comprehensive knowledge of pharmaceutical manufacturing processes. Daniel has an extensive background in validation and product life cycle management having been responsible for managing a multitude of products from ideation, through launch and sustainability.